Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Ultromics
UltromicsUltromics Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Ultromics match what happens in practice?
Still openWhether the reported magnitude holds in practice, and in which specialties it does not.
Public evidence
Ultromics secures £41m Series C funding to expand AI solution - Home | Digital Health
GoogleNews:startup_funding:Ultromics
Public evidence
Ultromics funding signal
Google News
Public evidence
Ultromics funding signal
Google News
Public evidence
Ultromics funding signal
Google News
Public evidence
Ultromics funding signal
Google News
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 18 public external signal(s) across 4 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Ultromics through deployment evidence, company records, external market activity and clinician experience.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Ultromics. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Ultromics is an AI-powered software platform that integrates with existing echocardiography systems. It analyzes cardiac ultrasound images to identify structural and functional patterns indicative of heart failure.According to Ultromics
What Ultromics states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The AI platform detects patterns of diastolic dysfunction and structural abnormalities in echocardiograms.
According to Ultromics
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Recent change
Ultromics secures £41m Series C funding to expand AI solution - Home | Digital Health
Reported publicly
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
Ultromics provides FDA-cleared AI-powered echocardiogram analysis technology that assists cardiologists in detecting cardiac conditions, with a particular focus on heart failure with preserved ejection fraction (HFpEF) — a condition that is notoriously difficult to diagnose using traditional echocardiography…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Parent Company
Ultromicsvendor
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Ultromics accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence